Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment | Journal of Experimental & Clinical Cancer Research | Full Text

Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment | Journal of Experimental & Clinical Cancer Research | Full Text

Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment

Hepatocellular carcinoma (HCC) is one of the most common malignancies today. Patients suffer from HCC since its high malignancy and limited treatment means. With the development of genetic research, new therap...

Authors:Xiaoling Wu, Weijie Ma, Chengjie Mei, Xi Chen, Ye Yao, Yingyi Liu, Xian Qin and Yufeng Yuan

Citation:Journal of Experimental & Clinical Cancer Research 2020 39:97

Content type:Review

 

Published on: 1 June 2020

• ViewFull Text
 
• ViewPDF